Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A U Gerber

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Schweizerische Medizinische Wochenschrift|January 15, 1983
[What does the minimal inhibitory concentration of an antibiotic hide from the clinician? Experimental examples]A U Gerber, C Feller-Segessenmann, W A Craig
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1990
Simulation of human pharmacokinetic profiles in mice, and impact on antimicrobial efficacy of netilmicin, ticarcillin and ceftazidime in the peritonitis-septicemia modelA U Gerber, T Stritzko, C Segessenmann, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1993
The impact of the pre-treatment interval on antimicrobial efficacy in a biological modelA U Gerber, U Greter, C Segessenmann, et al.
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Pharmacodynamic determinants of imipenem's efficacy in a man-adapted animal modelU Flückiger, A U Gerber, C Segessenmann, et al.
Schweizerische Medizinische Wochenschrift|December 10, 1983
[Bolus injection, short infusion or intravenous drip of aminoglycoside antibiotics? In vivo study with netilmicin and Pseudomonas aeruginosa]H P Brugger, A U Gerber, C Feller-Segessenmann
Reviews of Infectious Diseases|March 1, 1983
Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal functionR A Greenfield, A U Gerber, W A Craig
Drugs|January 1, 1996
Use of antimicrobials in Swiss hospitals. Swiss Committee of Anti-Infective AgentsD P Lew, J Garbino, A U Gerber, et al.
The Journal of Infectious Diseases|April 1, 1982
Constant infusions vs. intermittent doses of gentamicin against Pseudomonas aeruginosa in vitroA U Gerber, P Wiprächtiger, U Stettler-Spichiger, et al.
The Journal of Infectious Diseases|November 1, 1982
Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo modelA U Gerber, A P Vastola, J Brandel, et al.
The Journal of Infectious Diseases|January 1, 1986
Antibiotic therapy of infections due to Pseudomonas aeruginosa in normal and granulocytopenic mice: comparison of murine and human pharmacokineticsA U Gerber, H P Brugger, C Feller, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Schweizerische Medizinische Wochenschrift|January 15, 1983
[What does the minimal inhibitory concentration of an antibiotic hide from the clinician? Experimental examples]A U Gerber, C Feller-Segessenmann, W A Craig
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1990
Simulation of human pharmacokinetic profiles in mice, and impact on antimicrobial efficacy of netilmicin, ticarcillin and ceftazidime in the peritonitis-septicemia modelA U Gerber, T Stritzko, C Segessenmann, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1993
The impact of the pre-treatment interval on antimicrobial efficacy in a biological modelA U Gerber, U Greter, C Segessenmann, et al.
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Pharmacodynamic determinants of imipenem's efficacy in a man-adapted animal modelU Flückiger, A U Gerber, C Segessenmann, et al.
Schweizerische Medizinische Wochenschrift|December 10, 1983
[Bolus injection, short infusion or intravenous drip of aminoglycoside antibiotics? In vivo study with netilmicin and Pseudomonas aeruginosa]H P Brugger, A U Gerber, C Feller-Segessenmann
Reviews of Infectious Diseases|March 1, 1983
Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal functionR A Greenfield, A U Gerber, W A Craig
Drugs|January 1, 1996
Use of antimicrobials in Swiss hospitals. Swiss Committee of Anti-Infective AgentsD P Lew, J Garbino, A U Gerber, et al.
The Journal of Infectious Diseases|April 1, 1982
Constant infusions vs. intermittent doses of gentamicin against Pseudomonas aeruginosa in vitroA U Gerber, P Wiprächtiger, U Stettler-Spichiger, et al.
The Journal of Infectious Diseases|November 1, 1982
Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo modelA U Gerber, A P Vastola, J Brandel, et al.
The Journal of Infectious Diseases|January 1, 1986
Antibiotic therapy of infections due to Pseudomonas aeruginosa in normal and granulocytopenic mice: comparison of murine and human pharmacokineticsA U Gerber, H P Brugger, C Feller, et al.
Pageof 5